Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Holocene Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$364M	Sell	2,611,826 -1,552,612	-37%	-$217M	0.88%	22
2025 Q4	$511M	Buy	4,164,438 +1,547,266	+59%	+$188M	1.07%	10
2025 Q3	$291M	Sell	2,617,172 -1,609,799	-38%	-$183M	0.66%	40
2025 Q2	$469M	Buy	4,226,971 +1,919,100	+83%	+$204M	1.14%	11
2025 Q1	$259M	Buy	+2,307,871	New	+$238M	0.75%	33
2022 Q2	–	Sell	-25,713	Closed	-$1.53M	–	891
2022 Q1	$1.53M	Buy	+25,713	New	+$1.64M	0.01%	599
2021 Q2	–	Sell	-2,038,262	Closed	-$132M	–	872
2021 Q1	$132M	Buy	2,038,262 +811,897	+66%	+$52.4M	0.83%	24
2020 Q4	$71.4M	Buy	+1,226,365	New	+$74M	0.45%	69
2018 Q2	–	Sell	-3,316	Closed	-$250K	–	626
2018 Q1	$250K	Sell	3,316 -6,127	-65%	-$487K	0.01%	445
2017 Q4	$676K	Buy	+9,443	New	+$717K	0.02%	320

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Holocene Advisors's GILD Position: Q1 2026 in Review

Holocene Advisors reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $217M and leaving 2,611,826 shares worth $364M. The position accounts for 0.88% of the portfolio, ranked #22.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 10 quarters since. The position peaked at $511M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Holocene Advisors held 2,611,826 shares of Gilead Sciences worth $364M as of Q1 2026.
Holocene Advisors sold 1,552,612 Gilead Sciences shares in Q1 2026, an estimated $217M.
Gilead Sciences made up 0.88% of Holocene Advisors's portfolio in Q1 2026, its #22 holding.
Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 10 quarters since.
Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.